Literature DB >> 32112857

COVID-19: Zoonotic aspects.

Tauseef Ahmad1, Muhammad Khan2, Taha Hussein Musa1, Saima Nasir3, Jin Hui1, D Katterine Bonilla-Aldana4, Alfonso J Rodriguez-Morales5.   

Abstract

Entities:  

Keywords:  2019-New coronavirus; China; Outbreak; Transmission

Mesh:

Year:  2020        PMID: 32112857      PMCID: PMC7128549          DOI: 10.1016/j.tmaid.2020.101607

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
Dear Editor Coronaviruses can cause severe diseases in humans and animals, as has been stated recently by Biscayart et al. [1]. China has experienced several viral outbreaks in the last three decades; avian influenza outbreak in 1997, severe acute respiratory syndrome (SARS) in 2003 [2], and severe fever with thrombocytopenia syndrome (SFTS) in 2010 [3]. In China, yet another pathogenic human coronavirus outbreak was reported in the city of Wuhan, Hubei province. Wuhan is an urban town located in the central part of China. It is one of the significant transportations and business hubs. In 2018, the city comprised of a population of approximately 11.9 million, and one of the seventh most populous Chinese city [1,4]. On December 12, 2019, the Wuhan Municipal Health Commission (WMHC) reported 27 individuals infected by a new coronavirus designated initially as 2019-novel coronavirus (2019-nCoV), and later as Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). Of the reported cases, seven were critically ill and had a history of exposure with the Seafood Wholesale Market. An early study conducted in January 2020, among 41 patients (median age 49 years), positive for SARS-CoV-2 infection (the causative agent of COVID-19), found that half of them had underlying diseases, including diabetes 20%, cardiovascular disease 15%, and hypertension 15%. Their symptoms were mainly fever 98%, cough 76%, and fatigue 44%. The COVID-19 severe complications in such patients included respiratory distress syndrome 29%, RNAaemia 15%, acute cardiac injury 12%, and other secondary infections. Of the total infected patients, 32% were admitted to an Intensive Care Unit (ICU). The death rate was 15% [5]. Emerging viruses that spread to humans from an animal host are proven to be some of the deadliest diseases known [2,3]. COVID-19 is thought to be transmitted from the animals, though it has not yet been clear exactly from which animal, however the animals have been the sources of transmission as described in Fig. 1 . The recent finding shows that SARS-CoV-2 is 96% identical to a bat coronavirus [2]. We aimed to discuss the zoonotic transmission of SARS-CoV-2 to humans.
Fig. 1

Potential transmission cycles of SARS-CoV2 (formerly 2019nCoV).

Potential transmission cycles of SARS-CoV2 (formerly 2019nCoV). In the last few weeks, the number of cases has been increased and pose a threat to public health. The region Wuhan is the potential hotspots of coronavirus infection in China. Daily, the number of cases has been significantly increased, and be tracked at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. The overall case fatality rate has been stable for weeks less than 3%. However, an increased number of cases in China and outside posed an international emergency. Therefore, countries with limited resources prepared and strengthen the disease surveillance system to report and diagnose any case of COVID-19. Coronaviruses were identified in the mid-1960s and known to infect humans and other animals, including birds and mammals. Epithelial cells in the respiratory and gastrointestinal tract are the primary target cells. Due to these characters, viral shedding occurs via these systems and transmission can occur through different routes, i.e., fomites, airborne or fecal-oral. To date, seven coronaviruses have been shown to infect humans. Common human coronaviruses Betacoronavirus HCoV-OC43 and HCoV-HKU1, as well as Alphacoronavirus HCoV-229E, cause common colds and severe lower respiratory tract infections in infants and elderly, while Alphacoronavirus HCoV-NL63 is found to be a significant cause of (pseudo) croup and bronchiolitis in children [1]. New zoonotic coronaviruses have emerged and caused outbreaks in humans; SARS-CoV (2002, Betacoronavirus, subgenus Sarbecovirus), and MERS-CoV (2012, Betacoronavirus, subgenus Merbecovirus). In late 2019, a novel coronavirus related to a cluster of pneumonia cases in Wuhan, China (2019-nCoV), was identified. After that the disease designed as COVID-19. The SARS-CoV-2 is closely related to SARS-CoV and genetically clusters within Betacoronavirus subgenus Sarbecovirus [1]. An early study conducted by Li and colleagues reported that of the total 425 patients’ (median age was 59 years) highest number of cases, 55% had a history of Seafood Wholesale Market. Besides, 56% of patients were male, and the mean incubation period was 5.2 days. The Seafood market located at Wuhan, where different types of wild (snakes and marmots) and domesticated (poultry and bats) animals were sold illegally. Thus, suggested the disease may be transmitted from animals to humans (Fig. 1). Till now, the specific source and reservoir of SARS-CoV-2 are not explicitly known yet. During the COVID-19 outbreak, although earlier transmissions were from the animals after reporting four individuals from Seafood Wholesale Market, all other transmissions are believed to be from human to human (Fig. 1). This mode of transmission was so active that within a few days, it flew to other countries. A recent study identified human to human transmission of COVID-19. A Chinese (Shanghai resident) between January 19, 2020 and January 22, 2020 had visited Germany. During her stay in Germany, she developed no signs and symptoms of COVID-19, but she was tested positive after came back to China on January 26, 2020. On January 24, 2020, a 33 years old German businessman became ill had chills, sore throat, and myalgias. The patient history showed that he had a meeting with a Chinese business partner on 20 and January 21, 2020. Later, on January 28, 2020, another three employees at the company were found positive for COVID-19. Animal to human transmission can be reduced more quickly as compared to humans [2]. In the recent outbreak, transmission from humans to humans increased many folds due to annual celebrations in China during which the movement of the masses increased allot. Human to human transmission can happen in several ways. It can be through the droplets from the cough or sneeze, surfaces of public transport, restaurants, and other public places (toilets, elevators, bus stops). As have occurred in the past with other zoonotic conditions [2], the spillover of a new coronavirus, SARS-CoV-2, is now significant. Originating in bats, current and previous coronaviruses, such as SARS-CoV and MERS-CoV, are a matter of concern in the interaction between animals and humans, with the future concern of new epidemics in China and abroad.

Author contributions

Conceptualization: TA and MK. Data curation: TA. Writing—original draft preparation: TA. Writing—review, and editing: TA, MK, H, THM, SN, DKB-A, and AJR-M. Supervision and funding acquisition: JH.

Ethical approval

Approval was not required.

Funding source

This study was financially supported by Jiangsu Provincial Six Talent Peak, grant number WSN‐002. The funder had no role in study design, data collection, drafting of the manuscript, and submission.

CRediT authorship contribution statement

Tauseef Ahmad: Writing - original draft. Muhammad Khan: Writing - review & editing, Writing - original draft. Haroon: Writing - review & editing. Taha Hussein Musa: Writing - review & editing. Saima Nasir: Writing - review & editing. Jin Hui: Writing - review & editing. D.Katterine Bonilla-Aldana: Writing - review & editing. Alfonso J. Rodriguez-Morales: Writing - review & editing, Writing - original draft.

Declaration of competing interest

All authors report no potential conflicts. All authors have submitted the Form for Disclosure of Potential.
  4 in total

1.  Severe fever with thrombocytopenia syndrome - A bibliometric analysis of an emerging priority disease.

Authors:  Alfonso J Rodríguez-Morales; Valeria Ramírez-Jaramillo; Andrés Mauricio Patiño-Barbosa; Hugo Alejandro Bedoya-Arias; Valentina Henao-SanMartin; David Ricardo Murillo-García; Jaime A Cardona-Ospina; Guillermo J Lagos-Grisales
Journal:  Travel Med Infect Dis       Date:  2018-04-19       Impact factor: 6.211

2.  The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? - Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI).

Authors:  Cristian Biscayart; Patricia Angeleri; Susana Lloveras; Tânia do Socorro Souza Chaves; Patricia Schlagenhauf; Alfonso J Rodríguez-Morales
Journal:  Travel Med Infect Dis       Date:  2020-01-30       Impact factor: 6.211

3.  The first 2019 novel coronavirus case in Nepal.

Authors:  Anup Bastola; Ranjit Sah; Alfonso J Rodriguez-Morales; Bibek Kumar Lal; Runa Jha; Hemant Chanda Ojha; Bikesh Shrestha; Daniel K W Chu; Leo L M Poon; Anthony Costello; Kouichi Morita; Basu Dev Pandey
Journal:  Lancet Infect Dis       Date:  2020-02-10       Impact factor: 25.071

4.  Are we ready for the new fatal Coronavirus: scenario of Pakistan?

Authors:  Tauseef Ahmad; Muhammad Khan; Fazal Mehmood Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-02-12       Impact factor: 3.452

  4 in total
  28 in total

1.  A study of plithogenic graphs: applications in spreading coronavirus disease (COVID-19) globally.

Authors:  Fazeelat Sultana; Muhammad Gulistan; Mumtaz Ali; Naveed Yaqoob; Muhammad Khan; Tabasam Rashid; Tauseef Ahmed
Journal:  J Ambient Intell Humaniz Comput       Date:  2022-04-04

Review 2.  The intricate association of COVID-19 pandemic with ecological issues.

Authors:  Sangeeta Deka; Diksha Rani; Putul Mahanta; Deepjyoti Kalita
Journal:  J Family Med Prim Care       Date:  2022-05-14

3.  Decision-making framework for identifying regions vulnerable to transmission of COVID-19 pandemic.

Authors:  Rohit Gupta; Bhawana Rathore; Abhishek Srivastava; Baidyanath Biswas
Journal:  Comput Ind Eng       Date:  2022-04-29       Impact factor: 7.180

4.  Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.

Authors:  Wei Zhen; Ryhana Manji; Elizabeth Smith; Gregory J Berry
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

5.  Community-Based Assessment of Knowledge, Attitude, Practices and Risk Factors Regarding COVID-19 Among Pakistanis Residents During a Recent Outbreak: A Cross-Sectional Survey.

Authors:  Muhammad Sohail Afzal; Aisha Khan; Ubaid Ur Rahman Qureshi; Sadia Saleem; Muhammad Arif Nadeem Saqib; Rana Muhammad Kamran Shabbir; Muhammad Naveed; Muhammad Jabbar; Sarmad Zahoor; Haroon Ahmed
Journal:  J Community Health       Date:  2021-06

6.  View of Pakistani Residents toward Coronavirus Disease (COVID-19) during a Rapid Outbreak: A Rapid Online Survey.

Authors:  Khezar Hayat; Meagen Rosenthal; Sen Xu; Muhammad Arshed; Pengchao Li; Panpan Zhai; Gebrehaweria Kassa Desalegn; Yu Fang
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

Review 7.  An analysis of threats, strategies, and opportunities for African rhinoceros conservation.

Authors:  Admire Chanyandura; Victor K Muposhi; Edson Gandiwa; Never Muboko
Journal:  Ecol Evol       Date:  2021-05-01       Impact factor: 2.912

8.  In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.

Authors:  Sakshi Piplani; Puneet Kumar Singh; David A Winkler; Nikolai Petrovsky
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

Review 9.  Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.

Authors:  Chunting He; Ming Qin; Xun Sun
Journal:  Acta Pharm Sin B       Date:  2020-05-30       Impact factor: 11.413

Review 10.  An updated min-review on environmental route of the SARS-CoV-2 transmission.

Authors:  Edris Hoseinzadeh; Mahdi Farzadkia; Farshid Mohammadi; Hooshyar Hossini; Mahmoud Taghavi
Journal:  Ecotoxicol Environ Saf       Date:  2020-07-09       Impact factor: 6.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.